top of page
About
The purpose of this study is to evaluate the efficacy, safety, and tolerability of povetacicept in participants with primary membranous nephropathy (pMN).
Eligibility
Diagnosed with pMN with confirmatory historical biopsy. If no historical biopsy was performed that confirmed pMN, a biopsy can be performed during Screening to confirm eligibility​​
**There are other requirements for taking part in this study.**
If you qualify, you may receive at no cost:
-
Close care and follow-up throughout the study.
-
Participants will be compensated for taking part in the study
If you’re interested in participating in one of our Research Studies:
Call
303-232-3366
ext 2150, 2170, 2190 or 7330
bottom of page